• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The best pharmaceuticals for children-what can we do?

作者信息

Li Hao, Shi Fang-Hong, Huang Shi-Ying, Zhang Shun-Guo, Chen Hui-Wen

机构信息

Department of Pharmacy, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Clinical Research Center, Shanghai Children's Medical Center, National Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

出版信息

Transl Pediatr. 2020 Apr;9(2):86-92. doi: 10.21037/tp.2020.02.07.

DOI:10.21037/tp.2020.02.07
PMID:32477907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7237966/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d74b/7237966/0a1e70d70240/tp-09-02-86-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d74b/7237966/7d7895a6c1c0/tp-09-02-86-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d74b/7237966/0a1e70d70240/tp-09-02-86-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d74b/7237966/7d7895a6c1c0/tp-09-02-86-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d74b/7237966/0a1e70d70240/tp-09-02-86-f2.jpg

相似文献

1
The best pharmaceuticals for children-what can we do?儿童最佳药物——我们能做些什么？
Transl Pediatr. 2020 Apr;9(2):86-92. doi: 10.21037/tp.2020.02.07.
2
The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.2002年《儿童最佳药品法案》：自愿激励机制的兴起以及国会拒绝要求进行儿科测试。
Harvard J Legis. 2003 Winter;40(1):133-93.
3
The Comparison of Accidental Poisonings Between Pharmaceuticals and Nonpharmaceuticals in Children Younger than 3 Years.3岁以下儿童药物性与非药物性意外中毒的比较
Pediatr Emerg Care. 2015 Dec;31(12):825-9. doi: 10.1097/PEC.0000000000000506.
4
Give them what they want? The permissibility of pediatric placebo-controlled trials under the best pharmaceuticals for children act.给他们想要的？《儿童最佳药物法案》下儿科安慰剂对照试验的可允许性。
Ann Health Law. 2007 Winter;16(1):79-138, table of contents.
5
Development and optimization of the SPE procedure for determination of pharmaceuticals in water samples by HPLC-diode array detection.发展和优化 SPE 程序，通过 HPLC-二极管阵列检测测定水样中的药物。
J Sep Sci. 2010 Feb;33(2):258-67. doi: 10.1002/jssc.200900571.
6
Children and medicines: self-treatment of common illnesses among Luo schoolchildren in western Kenya.儿童与药物：肯尼亚西部洛族学童对常见疾病的自我治疗
Soc Sci Med. 2000 Jun;50(12):1771-83. doi: 10.1016/s0277-9536(99)00428-1.
7
Development and validation of a comprehensive solid-phase extraction method followed by LC-TOF/MS for the analysis of eighteen pharmaceuticals in influent and effluent of sewage treatment plants.开发并验证了一种全面的固相萃取方法，随后采用 LC-TOF/MS 对污水处理厂进、出水样中的 18 种药物进行分析。
Anal Bioanal Chem. 2018 Aug;410(20):4829-4846. doi: 10.1007/s00216-018-1120-9. Epub 2018 May 28.
8
Ranking of pharmaceuticals detected in the environment: aggregation and weighting procedures.环境中检测到的药品排名：汇总与加权程序。
Comb Chem High Throughput Screen. 2008 Dec;11(10):770-82. doi: 10.2174/138620708786734299.
9
Uptake of pharmaceuticals acts as an abiotic stress and triggers variation of jasmonates in Malabar spinach (Basella alba. L).药物摄取会对植物造成非生物胁迫，并引发Malabar 菠菜（Basella alba. L）中茉莉酸的变化。
Chemosphere. 2019 Dec;236:124711. doi: 10.1016/j.chemosphere.2019.124711. Epub 2019 Aug 29.
10
Adsorptive removal of selected pharmaceuticals by mesoporous silica SBA-15.介孔二氧化硅SBA-15对选定药物的吸附去除
J Hazard Mater. 2009 Sep 15;168(2-3):602-8. doi: 10.1016/j.jhazmat.2009.02.072. Epub 2009 Feb 23.

引用本文的文献

1
Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children.用于儿童按需治疗潜伏性结核病的三维打印异烟肼咀嚼凝胶
Pharmaceutics. 2025 May 17;17(5):658. doi: 10.3390/pharmaceutics17050658.
2
Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies.儿科药物研发：通过追踪创新疗法审视挑战与机遇。
Pharmaceutics. 2023 Oct 6;15(10):2431. doi: 10.3390/pharmaceutics15102431.

本文引用的文献

1
A Wish List for Drug Development in Pediatrics.儿科药物研发的愿望清单。
J Pharm Sci. 2020 Feb;109(2):939-943. doi: 10.1016/j.xphs.2019.10.029. Epub 2019 Oct 30.
2
Trends in Off-Label Drug Use in Ambulatory Settings: 2006-2015.门诊环境中药物标签外使用的趋势：2006-2015 年。
Pediatrics. 2019 Oct;144(4). doi: 10.1542/peds.2019-0896. Epub 2019 Sep 16.
3
Pediatric drug development in China: Reforms and challenges.中国儿科药物研发：改革与挑战。
Pharmacol Res. 2019 Oct;148:104412. doi: 10.1016/j.phrs.2019.104412. Epub 2019 Sep 3.
4
Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment.美国食品药品监督管理局未给出适应症并不应限制获得适当治疗的机会。
J Am Acad Dermatol. 2019 Feb;80(2):577-578. doi: 10.1016/j.jaad.2018.09.016. Epub 2018 Sep 20.
5
More medicines for children: impact of the EU paediatric regulation.更多儿童用药：欧盟儿科法规的影响。
Arch Dis Child. 2018 Jun;103(6):557-564. doi: 10.1136/archdischild-2017-313309. Epub 2018 Feb 28.
6
Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials.未成年父母所生孩子参与临床试验的伦理考量。
Paediatr Drugs. 2018 Jun;20(3):215-222. doi: 10.1007/s40272-017-0280-y.
7
Leveraging Big Data in Pediatric Development Programs: Proceedings From the 2016 American College of Clinical Pharmacology Annual Meeting Symposium.利用大数据于儿科开发项目：2016 年美国临床药理学会年会座谈会的会议录。
Clin Pharmacol Ther. 2018 Jul;104(1):81-87. doi: 10.1002/cpt.975. Epub 2018 Jan 10.
8
10 years EU regulation of pediatric medicines - impact on cardiovascular drug formulations.10 年欧盟儿科药物监管——对心血管药物制剂的影响。
Expert Opin Drug Deliv. 2018 Mar;15(3):261-270. doi: 10.1080/17425247.2018.1420054. Epub 2017 Dec 28.
9
Application of the FDA Biosimilar Extrapolation Framework to Make Off-Label Determinations.FDA 生物类似药外推框架在标签外使用的判定。
J Manag Care Spec Pharm. 2017 Dec;23(12):1227-1232. doi: 10.18553/jmcp.2017.23.12.1227.
10
Characteristics and Changes of Pediatric Therapeutic Trials under the Best Pharmaceuticals for Children Act.《儿童最佳药物法案》下儿科治疗试验的特点与变化
J Pediatr. 2018 Jan;192:8-12. doi: 10.1016/j.jpeds.2017.08.048. Epub 2017 Oct 10.